Weinmann, Jonas
Weis, Sabrina http://orcid.org/0000-0003-4800-9453
Sippel, Josefine
Tulalamba, Warut
Remes, Anca
El Andari, Jihad http://orcid.org/0000-0001-5502-6214
Herrmann, Anne-Kathrin
Pham, Quang H.
Borowski, Christopher
Hille, Susanne
Schönberger, Tanja
Frey, Norbert
Lenter, Martin
VandenDriessche, Thierry http://orcid.org/0000-0003-4230-745X
Müller, Oliver J. http://orcid.org/0000-0001-8223-2638
Chuah, Marinee K.
Lamla, Thorsten
Grimm, Dirk http://orcid.org/0000-0001-6227-5665
Article History
Received: 9 February 2020
Accepted: 29 September 2020
First Online: 28 October 2020
Competing interests
: D.G. is a co-founder and shareholder of AaviGen GmbH. Part of this work was conducted as a sponsored research agreement between the Grimm lab and Boehringer Ingelheim Pharma GmbH & Co. KG. J.W. has performed the studies reported here during his doctoral work at Heidelberg University Hospital and is now an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. D.G., J.E.A. and J.W. are inventors on a pending patent application (International application number: PCT/EP2019/060790; Publication number: WO/2019/207132) covering AAVMYO. T.S., M.L., and T.L. are employees of Boehringer Ingelheim Pharma GmbH & Co. KG. All other authors declare no competing interests.